Expression of beta-human chorionic gonadotropin in ovarian cancer tissue

The purpose of the present investigation was to determinate expression of human chorionic gonadotropin gene in ovarian cancer tissue. The study included 15 patients with epithelial ovarian carcinoma. The expression of mRNA hCGbeta was determinated by the RT PCR method and the distribution of the hormone in study tissue was analyzed immunohistochemicaly. In all 15 study specimens of the ovarian carcinoma tissue the active hCGbeta gene was found, whereas noncancerous tissue demonstrated lack of the hormone expression. Thus, the study clearly shows that the expression of hCGbeta is the feature of ovarian cancer tissue.

hCGβ; mRNA of hCGβ; Ovarian cancer

[1]Pierce J.G., Parson T.F.: "Glycoprotein hormones: structure and function". Annu. Rev. Biochem., 1981, 50, 465.

[2] Braunstein G.D., Karow W.G., Gentry W.C., Rasor J., Wade M.E.: "First-trimester chorionic gonadotropin measurements as an aid in the diagnosis of early pregnancy disorders". Am. J. Obstet. Gynecol., 1978, 131, 25.

[3] Bagshawe K.D.: "Choriocarcinoma. A model of tumor markers". Acta Oncol.. 1992, 31, 99.

[4] Hussa R.O.: "Human chorionic gonadotropin, a clinical marker review of its biosynthesis". Ligand Review, 1981, 3 (suppl. 2), 6.

[5] Ozturk M.: "Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease". J. Reprod. Med., 1991, 36, 21.

[6] McLoughlin J., Pepera T., Bridger J., Williams G.: "Serum and urinary levels of beta chorionic gonadotropin in patients with transitional cell carcinoma". Br. J. Cance,; 1991, 63, 822.

[7] Grossman M., Trautmann M.E., Poertl S., Hoermann R., Berger P., Arnold R., Mann K.: "Alfa-subunit and human chorionic gonadotropin-β immunoreactivity in patients with malignant endocrine gastroenteropancreatic tumors". Eur. J. Clin. Invest .. 1994, 24, 131.

[8] Szturmowicz M., W iatr E.. Sakowicz A., Slodkowska J.. Roszkowski K., Filipecki S., Rowinska-Zakrzewska E.:'The role of human chorionic gonadotropin仕subunit elevation in small-cell lung cancer patients". Can Res. Clin. Oncol.. 1995, 121, 309.

[9] Grossmann M., Hoermann R., Gocze P.M., Ott M., Berger P., Mann K.: "Measurement of human chorionic gonadotropinrelated immunoreactivity in serum, ascites and tumor cysts of patients with gynecologic malignancies". Eur. J. Clin. Invest.. 1995, 25, 867.

[10] Carpelan-Holmstrom M., Haglund C., Lundin J., Alfthan H., Stenman U.-H., Roberts P.J.: "Independent prognostic value of preoperative serum markers CA-125, specific tissue polypeptide antigen and human chorionic gonadotropin beta, but not carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer". Br. J. Cancer, 1996, 74, 925.

[11] Webb A., Scott-Mackie P., Cunningham D., Norman A., Andreyev J., O'Brien M., Bensted J.: "The prognostic value of serum and immunohistochemical tumor markers in advanced gastric cancer" Eur. J. Cancer, 1996, 32A, 63.

[12] Acevedo H.F., Krischevsky A., Campbell-Acevedo E.A., Galyon J.C., Buffo M.J., Hartsoch R.J.: "Flow cytometry method for the analysis of membrane-associated human chorionic gonadotropin, its subunits, and fragments on human cancer cells". Cancer, 1992, 69, 1818.

[13] Acevedo H.F., Krischevsky A., Campbell-Acevedo E.A., Galyon J.C., Buffo M.J., Hartsock R.J.: "Expression of membrane associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells". Cancer, 1992, 69, 1829.

[14] Lunardi-lskander Y., Bryant J.L., Zeman R.A., Lam V.H., Samaniego F., Besnier J.M. et al.: "Tumorigenesis and metast小is of neoplastic Kaposi's sarcoma cell line in immonodeficient mice blocked by a human pregnancy hormone". Nature, 1995, 375, 64.

[15] Gillott D.J., Iles R.k., Chard T.:'The effect of hCGβ on the in vitro growth of bladder cancer cells". Br. J. Cancer, 1996, 73, 323.

[16] Ind T., lies R.K., Shepherd J., Chard T.: "Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotropin as prognostic markers for epithelial ovarian cancer". Br. J. Ohstet. Gynecol., 1997, 104, 1024.

[17] Cole L.A., Schwartz P.E., Wang Y.X.: "Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. I. Sensitivity and specificity, comparison with other markers". Gynecol Oncol., 1988, 31, 82.

[18] Carter P.G., Iles R.K., Neven P.: "Measurement of urinary beta core fragment of human chorionic gonadotropin in women with vulvovaginal malignancy and it prognostic significance". Br. J. Cancer, 1995, 71, 350.

[19] Carter P.G., Iles R.K., Neveu P.: "The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix". Gynecol. Oneal., 1994, 55, 271.

[20] Laphorn A.J., Harris D.C., Littlejohn A., Lustbader J.W., Canfield R.E., Machin K.J. et al.: "Crystal structure of hCG". Nature, 1994, 369, 455.

[21] Wu H., Lustbader J.W., Liu Y., Canfield R.E., Hendrickson W.A.: "Structure of human chorionic gonadotropin at 2-6 A resolution from MAD analysis of the selenomethionyl protein". Structure, 1994, 2, 545.

[22] Murray-Rust J., McDonald N.Q., Blundell T.L、Hosang M., Oefner C., Winkler F., Bradshaw R.A.: "Topological similarities in TGF-P2, PDGF-BB and NGF define a superfamilly of polypeptide growth factors". Structure, 1993, 1, 153.

[23] Sun P.O., Davies D.R.: "The cystine-knot growth-factor superfamily". Ann. Rev. Biophys Biomolec. Struct., 1995, 24, 269.

[24] Gyevi A., Bartha E.: "Hormonal modulation of neuronal cells behavior in vitro". Folia Histochem. Cytobiol., 1990, 28, 145.

[25] Koj A., Rokital H., Pierzchalski P., Kordula T., Guz, Bereta J.: "Modulation of acute phase protein synthesis by cellular growth and differentiation factors". Folia Histochem. Cytobiol., 1992, 30, 143.

[26] Lundin M., Nordling S., Carpelan-Holmstrom M., Louhimo J., Alfthan H., Stenman U.H., Haglund C.: "A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer" Anticancer Res., 2000, 20, 4949.

[27] Louhimo J., Nordling S., Alfthan H., von Boguslawski K., Stenman U.H., Haghund C.: "Specific staining of human chorionic gonadotropin beta in benign and malignant gastrointestinal tissues with monoclonal antibodies". Histopath., 2001, 38, 418.